Abrahamson EE - Search Results

1

Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections.

Abrahamson EE, Moore RY. Abrahamson EE, et al. Brain Res. 2001 Oct 19;916(1-2):172-91. doi: 10.1016/s0006-8993(01)02890-6. Brain Res. 2001. PMID: 11597605

2

The posterior hypothalamic area: chemoarchitecture and afferent connections.

Abrahamson EE, Moore RY. Abrahamson EE, et al. Brain Res. 2001 Jan 19;889(1-2):1-22. doi: 10.1016/s0006-8993(00)03015-8. Brain Res. 2001. PMID: 11166682

3

The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems.

Abrahamson EE, Leak RK, Moore RY. Abrahamson EE, et al. Neuroreport. 2001 Feb 12;12(2):435-40. doi: 10.1097/00001756-200102120-00048. Neuroreport. 2001. PMID: 11209963

4

Lesions of suprachiasmatic nucleus efferents selectively affect rest-activity rhythm.

Abrahamson EE, Moore RY. Abrahamson EE, et al. Mol Cell Endocrinol. 2006 Jun 27;252(1-2):46-56. doi: 10.1016/j.mce.2006.03.036. Mol Cell Endocrinol. 2006. PMID: 16793198

5

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.

Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST. Ikonomovic MD, et al. Among authors: abrahamson ee. Brain. 2008 Jun;131(Pt 6):1630-45. doi: 10.1093/brain/awn016. Epub 2008 Mar 12. Brain. 2008. PMID: 18339640 Free PMC article.

6

Time course analysis of hippocampal nerve growth factor and antioxidant enzyme activity following lateral controlled cortical impact brain injury in the rat.

DeKosky ST, Taffe KM, Abrahamson EE, Dixon CE, Kochanek PM, Ikonomovic MD. DeKosky ST, et al. Among authors: abrahamson ee. J Neurotrauma. 2004 May;21(5):491-500. doi: 10.1089/089771504774129838. J Neurotrauma. 2004. PMID: 15165358

7

Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.

Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VM, Clark RS, Marion DW, Wisniewski SR, DeKosky ST. Ikonomovic MD, et al. Among authors: abrahamson ee. Exp Neurol. 2004 Nov;190(1):192-203. doi: 10.1016/j.expneurol.2004.06.011. Exp Neurol. 2004. PMID: 15473992

8

Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.

Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, Klunk WE, DeKosky ST, Kamboh MI. Desai PP, et al. Among authors: abrahamson ee. Neurobiol Dis. 2005 Nov;20(2):574-82. doi: 10.1016/j.nbd.2005.04.012. Neurobiol Dis. 2005. PMID: 15916898

9

Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, Debnath ML, Holt DP, Huang GF, Shao L, DeKosky ST, Price JC, Mathis CA. Klunk WE, et al. Among authors: abrahamson ee. J Neurosci. 2005 Nov 16;25(46):10598-606. doi: 10.1523/JNEUROSCI.2990-05.2005. J Neurosci. 2005. PMID: 16291932 Free PMC article.

10

X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.

Ikonomovic MD, Abrahamson EE, Isanski BA, Debnath ML, Mathis CA, Dekosky ST, Klunk WE. Ikonomovic MD, et al. Among authors: abrahamson ee. Methods Enzymol. 2006;412:123-44. doi: 10.1016/S0076-6879(06)12009-1. Methods Enzymol. 2006. PMID: 17046656 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results